Form 6-K XTL BIOPHARMACEUTICALS For: Dec 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
XTL Biopharm SP (XTLB) Swings to Q3 Loss
December 1, 2014 6:40 AM ESTXTL Biopharm SP (Nasdaq: XTLB) reported Q3 EPS of $-0.00, versus $0.00 reported last year. Revenue was $287 thousand, versus $473 thousand posted in Q313.
For earnings history and earnings-related data on XTL Biopharm SP (XTLB) click here.
... More